May 5, 2015 Clinical Research/Diagn. M&A, Partnerships

Pacific Biosciences Achieves Second Development Milestone in Clinical Diagnostics Agreement With Roche

MENLO PARK, Calif., May 5, 2015 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II Sequencing System, today announced that it has achieved a second development milestone under its development, commercialization and license agreement with F. Hoffman-La Roche Ltd (Roche), earning an additional $10 million.The development, commercialization and license... Read more

October 29, 2014 Clinical Research/Diagn. Mass Spectrometry Molecular Spectroscopy Product Launch

Analysis of Autofluorescence in Polymorphonuclear Neutrophils: A New Tool for Early Infection Diagnosis

Diagnosing bacterial infection (BI) remains a challenge for the attending physician. An ex vivo infection model based on human fixed polymorphonuclear neutrophils (PMNs) gives an autofluorescence signal that differs significantly between stimulated and unstimulated cells. We took advantage of this property for use in an in vivo pneumonia mouse model and in patients hospitalized with... Read more

February 24, 2014 Clinical Research/Diagn. Life Science Tools Product Launch

GE Announces New Offerings to Help Providers Manage Financial and Clinical Risk

Financial solutions meet today and tomorrow’s changing requirements Expanded relationship with Caradigm to address population health needs ORLANDO, FLORIDA — February 24, 2014 — GE Healthcare today announced new offerings from its $2B software investment targeting the rapidly emerging market for integrated care solutions. These new offerings combine software, services and a broad ecosystem of... Read more